Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

Summary Background In the Gynecologic Cancer Intergroup International Collaboration on Ovarian Neoplasms 7 (ICON7) trial, bevacizumab improved progression-free survival in patients with ovarian cancer when used in combination with first-line chemotherapy and as a single-drug continuation treatment f...

Full description

Saved in:
Bibliographic details
Volume: 14
Main Author: Stark, Dan, Dr
Nankivell, Matthew, MSc
Pujade-Lauraine, Eric, Prof
Kristensen, Gunnar, MD
Elit, Lorraine, MD
Stockler, Martin, MBBS
Hilpert, Felix, MD
Cervantes, Andrés, MD
Brown, Julia, MSc
Lanceley, Anne, PhD
Velikova, Galina, Prof
Sabate, Eduardo, MD
Pfisterer, Jacobus, Prof
Carey, Mark S, MD
Beale, Philip, MBBS
Qian, Wendi, PhD
Swart, Ann Marie, MRCP
Oza, Amit, FRCP
Perren, Tim, MD
Format: Journal Article
Language: English
Zielgruppe: Academic
Place of publication: NEW YORK Elsevier Ltd 2013
ELSEVIER SCIENCE INC
Elsevier B.V
Lancet Pub. Group
published in: The lancet oncology Vol. 14; no. 3; pp. 236 - 243
ORCID: 0000-0003-3793-8724
0000-0001-8472-8856
0000-0001-9143-9710
0000-0003-3806-3691
Data of publication: 2013
ISSN: 1470-2045
1474-5488
EISSN: 1474-5488
Discipline: Medicine
Subjects:
Online Access: available in Bonn?
Database: Web of Knowledge
Science Citation Index Expanded
Web of Science
Web of Science - Science Citation Index Expanded - 2013
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Academic OneFile (A&I only)
MEDLINE - Academic
OpenAIRE (Open Access)
OpenAIRE
PubMed Central (Full Participant titles)
Database information Databases - DBIS